Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/G1-THERAPEUTICS-INC-34912629/news/G1-Therapeutics-Initiates-Phase-2-Trial-to-Support-the-Antitumor-Mechanism-of-Action-MOA-of-Trilac-37178612/?utm_source=whatsapp&utm_medium=social&utm_campaign=share